Donepezil Hydrochloride NDC 24979-004

NDC codes

FDA NDC Directory

Product NDC (as listed)24979-004Labeler and product segments. Claims need a package NDC.

Product NDC at billing width24979-0004Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
24979-004-06	24979000406	30 TABLET, FILM COATED in 1 BOTTLE (24979-004-06)Marketed from Mar 1, 2015
24979-004-07	24979000407	90 TABLET, FILM COATED in 1 BOTTLE (24979-004-07)Marketed from Sep 22, 2015

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Donepezil Hydrochloride
Generic name (nonproprietary): donepezil hydrochloride
Active ingredients: Donepezil hydrochloride — 23 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Upsher-Smith Laboratories, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 203104
Marketing start: Mar 1, 2015
Listing expires: Dec 31, 2027
Other FDA classes: Cholinesterase Inhibitors (Mechanism)
Identifiers: Product ID 24979-004_625542d6-e84b-4a79-9c93-ab89bd9f5264SPL ID 625542d6-e84b-4a79-9c93-ab89bd9f5264SPL set ID 12a755c5-1ad9-43d1-832a-eb2ff17bd693RxCUI 1100184UNII 3O2T2PJ89DUPC 0324979004068, 0324979004075
Pharmacologic class: Cholinesterase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N424979000406 followed by a unit qualifier and the quantity

Package 24979-0004-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 8, 2026.

Indications (excerpt from the label)

Donepezil hydrochloride tablets are indicated for the treatment of dementia of the Alzheimer’s type. Efficacy has been demonstrated in patients with mild, moderate, and severe Alzheimer’s disease. Donepezil hydrochloride tablets are acetylcholinesterase inhibitor indicated for the treatment of dementia of the Alzheimer’s type. Efficacy has been demonstrated in patients with mild, moderate, and severe Alzheimer’s Disease ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 203104

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 203104
Product	Strength	Form · route	Labeler	Product NDC
Donepezil Hydrochloride	Donepezil hydrochloride 23 mg/1	Tablet, Film coatedOral	Bryant Ranch Prepack	72162-1276
Donepezil Hydrochloride	Donepezil hydrochloride 23 mg/1	Tablet, Film coatedOral	Bryant Ranch Prepack	63629-8483
Donepezil Hydrochloride	Donepezil hydrochloride 23 mg/1	Tablet, Film coatedOral	Proficient Rx LP	71205-948
Donepezil Hydrochloride	Donepezil hydrochloride 23 mg/1	Tablet, Film coatedOral	Golden State Medical Supply, Inc.	51407-320